Red Flags Detected

  • Going Concern (new) — Company now discloses substantial doubt about ability to continue operations for 12 months, citing cash of $7.7M insufficient to fund projected expenses.
NASDAQ: TPST Tempest Therapeutics, Inc. 10-K

Tempest pivots to CAR-T therapy via $20M asset deal, cuts staff 84%, flags going-concern doubt

Filed March 30, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 27, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.